Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy
Open Access
- 15 November 1992
- Vol. 70 (10) , 2524-2528
- https://doi.org/10.1002/1097-0142(19921115)70:10<2524::aid-cncr2820701022>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyThe Lancet, 1991
- Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.Journal of Clinical Oncology, 1991
- Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and VomitingAnnals of Internal Medicine, 1990
- Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy.Journal of Clinical Oncology, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.Journal of Clinical Oncology, 1985
- Neuronal 5-HT receptors in the peripheryNeuropharmacology, 1984
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981